Mersana Therapeutics Kicks Off A Major IPO Week
June 26, 2017 at 19:49 PM EDT
We like Mersana's partnerships with major pharma firms.The pipeline overall is OK and the company notes in its SEC Filings that post-IPO its goal is to file one new IND every 12-24 months. We recommend investors consider a modest allocation to MRSN.
